Comparison of endoscopic findings of Triamcinolone impregnated gelfoam with Triamcinolone impregnated Surgicel in nasal dressing after endoscopic sinus surgery in patients with polyposis

Comparison of satisfaction and bleeding of Triamcinolone impregnated gelfoam with Triamcinolone impregnated Surgicel in nasal dressing after endoscopic sinus surgery in patients with polyposis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150907023936N2

Enrollment

Registered

2018-08-11

Start date

2018-04-04

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis with polyposis. Nasal polyp

Interventions

Intervention 1: Intervention group: Triamcinolone impregnated gelfoam nasal dressing. Intervention 2: Control group: Triamcinolone impregnated surgicel nasal dressing.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18 to 65 years old Bilateral polyposis Diagnosis of chronic rhinosinusitis based on EPOS 2012 Chronic rhinosinusitis resistant to medical therapy

Exclusion criteria

Exclusion criteria: Any systemic or reheumatologic diseases related to nasal disorders like cystic fibrosis, wegner, sarcoidosis Other pathologies than polyposis such as inverted papilloma or neoplasms

Design outcomes

Primary

Measure	Time frame
Satisfaction. Timepoint: 1 day, 1 week, 2 weeks, 1 month, 3months, 6 months. Method of measurement: likert.	—

Secondary

Measure	Time frame
Bleeding. Timepoint: 1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months. Method of measurement: likert.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr shirin Irani

Tehran University of Medical Sciences

sh_irani@razi.tums.ac.ir+98 21 6670 8103

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026